应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TSHA Taysha Gene Therapies, Inc.
休市中 07-11 16:00:00 EDT
2.64
+0.09
+3.53%
盘后
2.65
+0.01
+0.38%
18:58 EDT
最高
2.73
最低
2.59
成交量
329.37万
今开
2.62
昨收
2.55
日振幅
5.29%
总市值
6.92亿
流通市值
4.88亿
总股本
2.62亿
成交额
875.54万
换手率
1.78%
流通股本
1.85亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Taysha Gene Therapies, Inc.盘中异动 急速上涨5.10%
市场透视 · 07-11 14:59
Taysha Gene Therapies, Inc.盘中异动 急速上涨5.10%
Taysha Gene Therapies, Inc.盘中异动 下午盘股价大涨5.13%
市场透视 · 07-08
Taysha Gene Therapies, Inc.盘中异动 下午盘股价大涨5.13%
Taysha Gene Therapies, Inc.盘中异动 股价大涨5.19%报2.43美元
市场透视 · 07-01
Taysha Gene Therapies, Inc.盘中异动 股价大涨5.19%报2.43美元
Taysha Gene Therapies, Inc.盘中异动 股价大跌5.33%
市场透视 · 06-26
Taysha Gene Therapies, Inc.盘中异动 股价大跌5.33%
Taysha Gene Therapies, Inc.盘中异动 临近收盘股价大跌5.02%
市场透视 · 06-24
Taysha Gene Therapies, Inc.盘中异动 临近收盘股价大跌5.02%
Taysha Gene Therapies, Inc.盘中异动 快速下跌5.45%
市场透视 · 06-20
Taysha Gene Therapies, Inc.盘中异动 快速下跌5.45%
Taysha Gene Therapies, Inc.盘中异动 股价大跌5.09%
市场透视 · 06-13
Taysha Gene Therapies, Inc.盘中异动 股价大跌5.09%
Taysha Gene Therapies, Inc.盘中异动 下午盘股价大跌5.00%
市场透视 · 06-10
Taysha Gene Therapies, Inc.盘中异动 下午盘股价大跌5.00%
Taysha Gene Therapies, Inc.盘中异动 早盘急速上涨5.03%
市场透视 · 06-06
Taysha Gene Therapies, Inc.盘中异动 早盘急速上涨5.03%
Taysha Gene Therapies, Inc.盘中异动 股价大涨5.21%报2.93美元
市场透视 · 06-03
Taysha Gene Therapies, Inc.盘中异动 股价大涨5.21%报2.93美元
Needham:重申Taysha Gene Therapies(TSHA.US)评级,由买入调整至买入评级, 目标价由6.00美元调整至8.00美元。
金融界 · 06-02
Needham:重申Taysha Gene Therapies(TSHA.US)评级,由买入调整至买入评级, 目标价由6.00美元调整至8.00美元。
摩根大通证券公司:维持Taysha Gene Therapies(TSHA.US)评级,由优于大市调整至优于大市评级, 目标价由5.00美元调整至6.00美元。
金融界 · 05-29
摩根大通证券公司:维持Taysha Gene Therapies(TSHA.US)评级,由优于大市调整至优于大市评级, 目标价由5.00美元调整至6.00美元。
Taysha Gene Therapies, Inc.盘中异动 早盘大幅上涨13.32%报2.77美元
市场透视 · 05-29
Taysha Gene Therapies, Inc.盘中异动 早盘大幅上涨13.32%报2.77美元
Taysha Gene Therapies, Inc.盘中异动 下午盘大幅下跌5.09%报2.61美元
市场透视 · 05-27
Taysha Gene Therapies, Inc.盘中异动 下午盘大幅下跌5.09%报2.61美元
Taysha Gene Therapies, Inc.2025财年第一财季实现净利润-21.53百万美元,同比增加10.52%
市场透视 · 05-23
Taysha Gene Therapies, Inc.2025财年第一财季实现净利润-21.53百万美元,同比增加10.52%
Taysha Gene Therapies, Inc.盘中异动 临近午盘大幅下挫5.02%
市场透视 · 05-22
Taysha Gene Therapies, Inc.盘中异动 临近午盘大幅下挫5.02%
Taysha Gene Therapies, Inc.盘中异动 早盘急速上涨5.20%
市场透视 · 05-20
Taysha Gene Therapies, Inc.盘中异动 早盘急速上涨5.20%
Taysha Gene Therapies, Inc.盘中异动 股价大涨11.60%
市场透视 · 05-15
Taysha Gene Therapies, Inc.盘中异动 股价大涨11.60%
Taysha Gene Therapies, Inc.盘中异动 股价大涨5.00%
市场透视 · 05-08
Taysha Gene Therapies, Inc.盘中异动 股价大涨5.00%
Taysha Gene Therapies, Inc.盘中异动 股价大涨6.64%
市场透视 · 05-02
Taysha Gene Therapies, Inc.盘中异动 股价大涨6.64%
加载更多
公司概况
公司名称:
Taysha Gene Therapies, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Taysha Gene Therapies, Inc.最初是根据德克萨斯州法律于2019年9月20日成立。该公司于2020年2月13日转换为特拉华州公司。该公司是一家以患者为中心的基因治疗公司,致力于开发和开发商业化基于AAV的基因疗法,用于治疗罕见和大量患者群体的中枢神经系统单基因疾病。
发行价格:
--
{"stockData":{"symbol":"TSHA","market":"US","secType":"STK","nameCN":"Taysha Gene Therapies, Inc.","latestPrice":2.64,"timestamp":1752264000000,"preClose":2.55,"halted":0,"volume":3293732,"hourTrading":{"tag":"盘后","latestPrice":2.65,"preClose":2.64,"latestTime":"18:58 EDT","volume":11392,"amount":30102.235,"timestamp":1752274688057},"delay":0,"floatShares":185000000,"shares":262000000,"eps":-0.334166,"marketStatus":"休市中","change":0.09,"latestTime":"07-11 16:00:00 EDT","open":2.62,"high":2.725,"low":2.59,"amount":8755449.455246,"amplitude":0.052941,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.334166,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"listingDate":1600920000000,"exchange":"NASDAQ","adjPreClose":2.55,"preHourTrading":{"tag":"盘前","latestPrice":2.63,"preClose":2.55,"latestTime":"09:29 EDT","volume":121885,"amount":319034.523794,"timestamp":1752240599944},"postHourTrading":{"tag":"盘后","latestPrice":2.65,"preClose":2.64,"latestTime":"18:58 EDT","volume":11392,"amount":30102.235,"timestamp":1752274688057},"volumeRatio":1.7088130357660738,"impliedVol":1.6474,"impliedVolPercentile":0.768},"requestUrl":"/m/hq/s/TSHA","defaultTab":"news","newsList":[{"id":"2550952740","title":"Taysha Gene Therapies, Inc.盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550952740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550952740?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:59","pubTimestamp":1752245956,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时59分,Taysha Gene Therapies, Inc.股票出现波动,股价急速拉升5.10%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.91%。其相关个股中,Mink Therapeutics, Inc.、Cel-Sci Corporation、Calcimedica, Inc.涨幅较大,Mink Therapeutics, Inc.、Cel-Sci Corporation、Dare Bioscience, Inc.较为活跃,换手率分别为500.58%、214.91%、82.76%,振幅较大的相关个股有Mink Therapeutics, Inc.、Cel-Sci Corporation、Lixte Biotechnology Holdings Inc C/Wts 30/11/2025 ,振幅分别为495.47%、74.61%、35.73%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711225916a4452178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711225916a4452178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2550229725","title":"Taysha Gene Therapies, Inc.盘中异动 下午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550229725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550229725?lang=zh_cn&edition=full","pubTime":"2025-07-09 01:18","pubTimestamp":1751995125,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日01时18分,Taysha Gene Therapies, Inc.股票出现波动,股价急速上涨5.13%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.60%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709011846a43e7cdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709011846a43e7cdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2548886941","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨5.19%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548886941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548886941?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:13","pubTimestamp":1751386412,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时13分,Taysha Gene Therapies, Inc.股票出现异动,股价急速上涨5.19%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为1.37%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020013329532c30f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020013329532c30f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2546575342","title":"Taysha Gene Therapies, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546575342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546575342?lang=zh_cn&edition=full","pubTime":"2025-06-27 01:33","pubTimestamp":1750959210,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日01时33分,Taysha Gene Therapies, Inc.股票出现波动,股价快速下挫5.33%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.33%。其相关个股中,Vor Biopharma Inc.、Moolec Science Sa C/Wts 、Adial Pharmaceuticals, Inc涨幅较大,Adial Pharmaceuticals, Inc、Plus Therapeutics, Inc.、Moleculin Biotech, Inc.较为活跃,换手率分别为1313.27%、299.94%、219.06%,振幅较大的相关个股有Vor Biopharma Inc.、Moolec Science Sa C/Wts 、Nls Pharmaceutics Ltd C/Wts 02/02/2026,振幅分别为98.85%、61.67%、46.79%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627013331a71f4088&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627013331a71f4088&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2546582092","title":"Taysha Gene Therapies, Inc.盘中异动 临近收盘股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546582092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546582092?lang=zh_cn&edition=full","pubTime":"2025-06-25 04:00","pubTimestamp":1750795230,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日04时00分,Taysha Gene Therapies, Inc.股票出现异动,股价急速下挫5.02%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为1.89%。其相关个股中,内克塔治疗、Apollomics Inc C/Wts 01/04/2028 、Eyenovia, Inc.涨幅较大,Eyenovia, Inc.、Nucana Plc、Adial Pharmaceuticals, Inc较为活跃,换手率分别为1439.13%、1051.14%、550.55%,振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、Immatics N V C/Wts 01/07/2025 、内克塔治疗,振幅分别为191.38%、156.58%、116.56%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625040030a71bbb8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625040030a71bbb8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2544178786","title":"Taysha Gene Therapies, Inc.盘中异动 快速下跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544178786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544178786?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:37","pubTimestamp":1750426645,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时37分,Taysha Gene Therapies, Inc.股票出现异动,股价大幅下跌5.45%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062021372597880a51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062021372597880a51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2543637888","title":"Taysha Gene Therapies, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543637888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543637888?lang=zh_cn&edition=full","pubTime":"2025-06-14 03:26","pubTimestamp":1749842815,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日03时26分,Taysha Gene Therapies, Inc.股票出现异动,股价急速下挫5.09%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。消息层面,截至03时26分,《坎托·菲茨杰拉德维持Taysha Gene Therapies买入评级,上调目标价至13美元》资讯为影响Taysha Gene Therapies, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614032655a7081db8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614032655a7081db8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2542344951","title":"Taysha Gene Therapies, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542344951","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542344951?lang=zh_cn&edition=full","pubTime":"2025-06-11 01:41","pubTimestamp":1749577307,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日01时41分,Taysha Gene Therapies, Inc.股票出现异动,股价快速下挫5.00%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.94%。其相关个股中,Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大,Nucana Plc、Windtree Therapeutics, Inc.、Carisma Therapeutics, Inc.较为活跃,换手率分别为31005.11%、2824.95%、1404.89%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Klotho Neurosciences, Inc.,振幅分别为261.54%、191.40%、114.83%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611014148a4a243e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611014148a4a243e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2541586347","title":"Taysha Gene Therapies, Inc.盘中异动 早盘急速上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541586347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541586347?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:36","pubTimestamp":1749216969,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时36分,Taysha Gene Therapies, Inc.股票出现异动,股价快速拉升5.03%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.74%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。该信息摘要如下:Needham:重申Taysha Gene Therapies评级,由买入调整至买入评级, 目标价由6.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213609a49cfef8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213609a49cfef8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2540777347","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨5.21%报2.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540777347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540777347?lang=zh_cn&edition=full","pubTime":"2025-06-03 21:49","pubTimestamp":1748958545,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日21时49分,Taysha Gene Therapies, Inc.股票出现波动,股价快速上涨5.21%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.56%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。该信息摘要如下:Needham:重申Taysha Gene Therapies评级,由买入调整至买入评级, 目标价由6.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603214905a6f8c1cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603214905a6f8c1cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2540202797","title":"Needham:重申Taysha Gene Therapies(TSHA.US)评级,由买入调整至买入评级, 目标价由6.00美元调整至8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2540202797","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540202797?lang=zh_cn&edition=full","pubTime":"2025-06-03 01:42","pubTimestamp":1748886174,"startTime":"0","endTime":"0","summary":"Needham:重申Taysha Gene Therapies(TSHA.US)评级,由买入调整至买入评级, 目标价由6.00美元调整至8.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/03014250813041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TSHA"],"gpt_icon":0},{"id":"2539260265","title":"摩根大通证券公司:维持Taysha Gene Therapies(TSHA.US)评级,由优于大市调整至优于大市评级, 目标价由5.00美元调整至6.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2539260265","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539260265?lang=zh_cn&edition=full","pubTime":"2025-05-29 21:41","pubTimestamp":1748526087,"startTime":"0","endTime":"0","summary":"摩根大通证券公司:维持Taysha Gene Therapies(TSHA.US)评级,由优于大市调整至优于大市评级, 目标价由5.00美元调整至6.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/29214150751132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["TSHA","399975","159848"],"gpt_icon":0},{"id":"2539653262","title":"Taysha Gene Therapies, Inc.盘中异动 早盘大幅上涨13.32%报2.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539653262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539653262?lang=zh_cn&edition=full","pubTime":"2025-05-29 21:32","pubTimestamp":1748525540,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日21时32分,Taysha Gene Therapies, Inc.股票出现异动,股价大幅拉升13.32%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。其相关个股中,Alzamend Neuro, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Polyrizon Ltd.涨幅较大,Alzamend Neuro, Inc.、Polyrizon Ltd.、Nucana Plc较为活跃,换手率分别为4801.42%、451.12%、238.35%,振幅较大的相关个股有Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Alzamend Neuro, Inc.、Aspire Biopharma Holdings, Inc.,振幅分别为26.28%、25.30%、22.95%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529213220a4916c38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529213220a4916c38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2538990884","title":"Taysha Gene Therapies, Inc.盘中异动 下午盘大幅下跌5.09%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538990884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538990884?lang=zh_cn&edition=full","pubTime":"2025-05-28 03:11","pubTimestamp":1748373110,"startTime":"0","endTime":"0","summary":"北京时间2025年05月28日03时11分,Taysha Gene Therapies, Inc.股票出现波动,股价急速下挫5.09%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.92%。其相关个股中,Imunon, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Nucana Plc、Imunon, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为688.25%、435.74%、259.64%,振幅较大的相关个股有Imunon, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Apollomics Inc C/Wts 01/04/2028 ,振幅分别为118.97%、74.51%、61.32%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528031150aa2c9ac4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528031150aa2c9ac4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2537153776","title":"Taysha Gene Therapies, Inc.2025财年第一财季实现净利润-21.53百万美元,同比增加10.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537153776","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537153776?lang=zh_cn&edition=full","pubTime":"2025-05-24 00:00","pubTimestamp":1748016042,"startTime":"0","endTime":"0","summary":"5月24日,Taysha Gene Therapies, Inc.公布财报,公告显示公司2025财年第一财季净利润为-21.53百万美元,同比增加10.52%;其中营业收入为2.30百万美元,同比减少32.55%,每股基本收益为-0.08美元。从资产负债表来看,Taysha Gene Therapies, Inc.总负债83.30百万美元,其中短期债务2.21百万美元,资产负债比为0.02,流动比率为0.06。机构评级:截至2025年5月24日,当前有10家机构对Taysha Gene Therapies, Inc.目标价做出预测,其中目标均价为7.05美元,其中最低目标价为5.00美元,最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000106a6ea7ce7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000106a6ea7ce7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA"],"gpt_icon":0},{"id":"2537306923","title":"Taysha Gene Therapies, Inc.盘中异动 临近午盘大幅下挫5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537306923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537306923?lang=zh_cn&edition=full","pubTime":"2025-05-22 23:45","pubTimestamp":1747928759,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日23时45分,Taysha Gene Therapies, Inc.股票出现波动,股价快速下挫5.02%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.52%。其相关个股中,Vigil Neuroscience, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Instil Bio, Inc.涨幅较大,Polyrizon Ltd.、Biodexa Pharmaceuticals Plc、Nucana Plc较为活跃,换手率分别为3967.16%、2251.87%、794.05%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Apollomics Inc C/Wts 01/04/2028 ,振幅分别为64.32%、62.90%、60.20%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522234559aa2c9735&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522234559aa2c9735&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2536641861","title":"Taysha Gene Therapies, Inc.盘中异动 早盘急速上涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536641861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536641861?lang=zh_cn&edition=full","pubTime":"2025-05-20 23:11","pubTimestamp":1747753903,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日23时11分,Taysha Gene Therapies, Inc.股票出现异动,股价急速拉升5.20%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.32%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Polyrizon Ltd.、Eyenovia, Inc.、Neuraxis, Inc.较为活跃,换手率分别为3815.06%、1466.10%、982.57%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Neuraxis, Inc.,振幅分别为174.55%、95.65%、85.46%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520231143a4859309&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520231143a4859309&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2535829875","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨11.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535829875","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535829875?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:32","pubTimestamp":1747315955,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时32分,Taysha Gene Therapies, Inc.股票出现波动,股价大幅上涨11.60%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.13%。其相关个股中,Nucana Plc、Abpro Holdings, Inc、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Nucana Plc、Polyrizon Ltd.、Abpro Holdings, Inc较为活跃,换手率分别为6340.33%、1847.45%、271.53%,振幅较大的相关个股有Nucana Plc、Pasithea Therapeutics Corp.、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为28.03%、20.55%、14.15%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213235a6e06d77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213235a6e06d77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2533158667","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533158667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533158667?lang=zh_cn&edition=full","pubTime":"2025-05-08 23:19","pubTimestamp":1746717544,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日23时19分,Taysha Gene Therapies, Inc.股票出现波动,股价快速拉升5.00%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为3.11%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050823190497536028&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050823190497536028&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2532084405","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨6.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532084405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532084405?lang=zh_cn&edition=full","pubTime":"2025-05-02 21:33","pubTimestamp":1746192797,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日21时33分,Taysha Gene Therapies, Inc.股票出现异动,股价快速上涨6.64%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为1.45%。其相关个股中,Polyrizon Ltd.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Adaptive Biotechnologies Corporation涨幅较大,Pmgc Holdings Inc.、Polyrizon Ltd.、Adial Pharmaceuticals, Inc较为活跃,换手率分别为205.35%、154.48%、59.72%,振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Polyrizon Ltd.、Adaptive Biotechnologies Corporation,振幅分别为67.34%、34.37%、18.34%。Taysha Gene Therapies, Inc.公司简介:泰莎基因疗法有限公司是一家以患者为中心的基因治疗公司,致力于根除单基因中枢神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213317aa2c81be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502213317aa2c81be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tayshagtx.com","stockEarnings":[{"period":"1week","weight":0.0776},{"period":"1month","weight":-0.0112},{"period":"3month","weight":1.1205},{"period":"6month","weight":0.5},{"period":"1year","weight":0.0732},{"period":"ytd","weight":0.526}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Taysha Gene Therapies, Inc.最初是根据德克萨斯州法律于2019年9月20日成立。该公司于2020年2月13日转换为特拉华州公司。该公司是一家以患者为中心的基因治疗公司,致力于开发和开发商业化基于AAV的基因疗法,用于治疗罕见和大量患者群体的中枢神经系统单基因疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.177294},{"month":2,"riseRate":0.4,"avgChangeRate":0.109391},{"month":3,"riseRate":0.2,"avgChangeRate":-0.123298},{"month":4,"riseRate":0.4,"avgChangeRate":0.009364},{"month":5,"riseRate":0.4,"avgChangeRate":0.055742},{"month":6,"riseRate":0.2,"avgChangeRate":-0.029545},{"month":7,"riseRate":0.6,"avgChangeRate":0.011515},{"month":8,"riseRate":0.75,"avgChangeRate":0.9233},{"month":9,"riseRate":0,"avgChangeRate":-0.14195},{"month":10,"riseRate":0,"avgChangeRate":-0.151796},{"month":11,"riseRate":0.6,"avgChangeRate":0.174321},{"month":12,"riseRate":0.6,"avgChangeRate":-0.073382}],"exchange":"NASDAQ","name":"Taysha Gene Therapies, Inc.","nameEN":"Taysha Gene Therapies, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Taysha Gene Therapies, Inc.(TSHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Taysha Gene Therapies, Inc.,TSHA,Taysha Gene Therapies, Inc.股票,Taysha Gene Therapies, Inc.股票老虎,Taysha Gene Therapies, Inc.股票老虎国际,Taysha Gene Therapies, Inc.行情,Taysha Gene Therapies, Inc.股票行情,Taysha Gene Therapies, Inc.股价,Taysha Gene Therapies, Inc.股市,Taysha Gene Therapies, Inc.股票价格,Taysha Gene Therapies, Inc.股票交易,Taysha Gene Therapies, Inc.股票购买,Taysha Gene Therapies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Taysha Gene Therapies, Inc.(TSHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}